Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Rozenblum

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Clinical Nuclear Medicine|February 13, 2020
18F-FDOPA PET/CT Findings in a Patient With Primary Cerebral AmyloidomaLaura Rozenblum, Marc Bertaux, Franck Bielle, et al.
Cancers|September 9, 2022
Role of Positron Emission Tomography in Primary Central Nervous System LymphomaLaura Rozenblum, Caroline Houillier, Carole Soussain, et al.
European Radiology|November 1, 2017
Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignanciesLaurent Dercle, Dana Hartl, Laura Rozenblum-Beddok, et al.
Current Oncology Reports|August 19, 2025
Multimodal Imaging to Improve Patient Selection and Optimize Treatment Planning and Delivery for Patients Undergoing Reirradiation: A Scoping ReviewArnaud Beddok, Laura Rozenblum, Valentin Calugaru, et al.
Oncotarget|May 4, 2018
Comparison and evaluation of two RGD peptides labelled with <sup>68</sup>Ga or <sup>18</sup>F for PET imaging of angiogenesis in animal models of human glioblastoma or lung carcinomaClaire Provost, Aurélie Prignon, Laura Rozenblum-Beddok, et al.
European Radiology|March 31, 2021
Simultaneously acquired PET and ASL imaging biomarkers may be helpful in differentiating progression from pseudo-progression in treated gliomasArnaud Pellerin, Maya Khalifé, Marc Sanson, et al.
European Radiology|November 11, 2022
Differentiating high-grade glioma progression from treatment-related changes with dynamic [<sup>18</sup>F]FDOPA PET: a multicentric studyLaura Rozenblum, Timothée Zaragori, Suzanne Tran, et al.
Scientific Reports|September 12, 2022
Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settingsMarine Soret, Jacques-Antoine Maisonobe, Serge Desarnaud, et al.
Clinical Nuclear Medicine|December 18, 2024
Cognitive Impairment and Brain Metabolic Changes in Post-Acute Sequelae of COVID-19: Insights From an [ 18 F]FDG PET/CT Cohort StudyLaura Rozenblum, Thomas Debroucker, Marie-Odile Habert, et al.
Neuro-Oncology|May 6, 2026
Automatic Extraction of PET RANO Criteria with an Externally Validated Deep Learning Model: Application to [18F]FDOPA PET ImagingTimothée Zaragori, Laura Rozenblum, Guido Rovera, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Clinical Nuclear Medicine|February 13, 2020
18F-FDOPA PET/CT Findings in a Patient With Primary Cerebral AmyloidomaLaura Rozenblum, Marc Bertaux, Franck Bielle, et al.
Cancers|September 9, 2022
Role of Positron Emission Tomography in Primary Central Nervous System LymphomaLaura Rozenblum, Caroline Houillier, Carole Soussain, et al.
European Radiology|November 1, 2017
Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignanciesLaurent Dercle, Dana Hartl, Laura Rozenblum-Beddok, et al.
Current Oncology Reports|August 19, 2025
Multimodal Imaging to Improve Patient Selection and Optimize Treatment Planning and Delivery for Patients Undergoing Reirradiation: A Scoping ReviewArnaud Beddok, Laura Rozenblum, Valentin Calugaru, et al.
Oncotarget|May 4, 2018
Comparison and evaluation of two RGD peptides labelled with <sup>68</sup>Ga or <sup>18</sup>F for PET imaging of angiogenesis in animal models of human glioblastoma or lung carcinomaClaire Provost, Aurélie Prignon, Laura Rozenblum-Beddok, et al.
European Radiology|March 31, 2021
Simultaneously acquired PET and ASL imaging biomarkers may be helpful in differentiating progression from pseudo-progression in treated gliomasArnaud Pellerin, Maya Khalifé, Marc Sanson, et al.
European Radiology|November 11, 2022
Differentiating high-grade glioma progression from treatment-related changes with dynamic [<sup>18</sup>F]FDOPA PET: a multicentric studyLaura Rozenblum, Timothée Zaragori, Suzanne Tran, et al.
Scientific Reports|September 12, 2022
Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settingsMarine Soret, Jacques-Antoine Maisonobe, Serge Desarnaud, et al.
Clinical Nuclear Medicine|December 18, 2024
Cognitive Impairment and Brain Metabolic Changes in Post-Acute Sequelae of COVID-19: Insights From an [ 18 F]FDG PET/CT Cohort StudyLaura Rozenblum, Thomas Debroucker, Marie-Odile Habert, et al.
Neuro-Oncology|May 6, 2026
Automatic Extraction of PET RANO Criteria with an Externally Validated Deep Learning Model: Application to [18F]FDOPA PET ImagingTimothée Zaragori, Laura Rozenblum, Guido Rovera, et al.
Pageof 5